News

Video

CIME 2025: Detecting, diagnosing, and treating glaucoma is a community effort, says I. Paul Singh, MD

Author(s):

At the 19th annual Controversies in Modern Eye Care (CIME), attendees from the dual ophthalmic and optometric spheres came together in Los Angeles, California. In the jam-packed lineup of scientific symposia, experts covered topics including cataract and refractive surgery and groundbreaking retinal therapies to revolutionizing demodex blepharitis care.

I. Paul Singh, MD, president of the Eye Centers of Racine & Kenosha, Wisconsin, met with the Eye Care Network to discuss his symposium, an update on contemporary glaucoma diagnosis techniques and patient monitoring strategies. The key to success in glaucoma care is collaboration and community, he said, with comanagement a foundational aspect of helping patients preserve and maintain vision.

"There are more glaucoma patients being diagnosed than ever before. The population is living longer. And we just don't have enough ophthalmologists and optometrists," Singh said. "We need this collaborative atmosphere."

In this video, Singh shares his approach to creating a successful community of care, as well as the contemporary diagnostic technologies he's most excited about.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
At the 2025 American Society of Cataract and Refractive Surgery (ASCRS) meeting, Seth Pantanelli, MD, speaks about the EyHance and enVista IOLs. Dr. Pantanelli is a professor of ophthalmology at Penn State College of Medicine in Hershey, Pennsylvania.
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
© 2025 MJH Life Sciences

All rights reserved.